Vector-based RNAi approaches for stable, inducible and genome-wide screens

被引：37

作者：

Fewell, Gwen D. ^{[1
]}

Schmitt, Karin ^{[1
]}

机构：

[1] Open Biosyst Inc, Huntsville, AL 35806 USA

来源：

DRUG DISCOVERY TODAY | 2006年 / 11卷 / 21-22期

关键词：

D O I：

10.1016/j.drudis.2006.09.008

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

RNA interference (RNAi) has revolutionized the study of biology and offers numerous applications in basic biology as well as in drug discovery research. Since the discovery of RNAi, several tools have been developed to enable loss-of-function studies in mammalian systems. The efficacy of RNAi is dependent on specific and versatile RNAi triggers that have evolved to enable transient, stable and in-vivo applications. Recently developed genome-wide short hairpin RNA (shRNA) and microRNA-adapted short hairpin RNA (shRNAmir) libraries incorporate advances in shRNA design and molecular 'barcodes' to enable more complex RNAi screens and the opportunity to progress to more complex genetics in whole animals.

引用

收藏

页码：975 / 982

页数：8

相关论文

共 53 条

[1] Yeast genome-wide drug-induced haploinsufficiency screen to determine drug mode of action [J].

Baetz, K ;

McHardy, L ;

Gable, K ;

Tarling, T ;

Rebérioux, D ;

Bryan, J ;

Andersen, RJ ;

Dunn, T ;

Hieter, P ;

Roberge, M .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (13) :4525-4530

[2] MicroRNAs: Genomics, biogenesis, mechanism, and function (Reprinted from Cell, vol 116, pg 281-297, 2004) [J].

Bartel, David P. .

CELL, 2007, 131 (04) :11-29

[3] A large-scale RNAi screen in human cells identifies new components of the p53 pathway [J].

Berns, K ;

Hijmans, EM ;

Mullenders, J ;

Brummelkamp, TR ;

Velds, A ;

Heimerikx, M ;

Kerkhoven, RM ;

Madiredjo, M ;

Nijkamp, W ;

Weigelt, B ;

Agami, R ;

Ge, W ;

Cavet, G ;

Linsley, PS ;

Beijersbergen, RL ;

Bernards, R .

NATURE, 2004, 428 (6981) :431-437

[4] 3′ UTR seed matches, but not overall identity, are associated with RNAi off-targets [J].

Birmingham, A ;

Anderson, EM ;

Reynolds, A ;

Ilsley-Tyree, D ;

Leake, D ;

Fedorov, Y ;

Baskerville, S ;

Maksimova, E ;

Robinson, K ;

Karpilow, J ;

Marshall, WS ;

Khvorova, A .

NATURE METHODS, 2006, 3 (03) :199-204

[5] Enhanced gene silencing of HIV-1 specific siRNA using microRNA designed hairpins [J].

Boden, D ;

Pusch, O ;

Silbermann, R ;

Lee, F ;

Tucker, L ;

Ramratnam, B .

NUCLEIC ACIDS RESEARCH, 2004, 32 (03) :1154-1158

[6] An shRNA barcode screen provides insight into cancer cell vulnerability to MDM2 inhibitors [J].

Brummelkamp, TR ;

Fabius, AWM ;

Mullenders, J ;

Madiredjo, M ;

Velds, A ;

Kerkhoven, RM ;

Bernards, R ;

Beijersbergen, RL .

NATURE CHEMICAL BIOLOGY, 2006, 2 (04) :202-206

[7] A system for stable expression of short interfering RNAs in mammalian cells [J].

Brummelkamp, TR ;

Bernards, R ;

Agami, R .

SCIENCE, 2002, 296 (5567) :550-553

[8] Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-κB [J].

Brummelkamp, TR ;

Nijman, SMB ;

Dirac, AMG ;

Bernards, R .

NATURE, 2003, 424 (6950) :797-801

[9] Germline transmission of RNAi in mice [J].

Carmell, MA ;

Zhang, LQ ;

Conklin, DS ;

Hannon, GJ ;

Rosenquist, TA .

NATURE STRUCTURAL BIOLOGY, 2003, 10 (02) :91-92

[10] TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing [J].

Chendrimada, TP ;

Gregory, RI ;

Kumaraswamy, E ;

Norman, J ;

Cooch, N ;

Nishikura, K ;

Shiekhattar, R .

NATURE, 2005, 436 (7051) :740-744

← 1 2 3 4 5 6 →